Case Report: Chemotherapy-Associated Systemic Sclerosis: Is DNA Damage to Blame?
Systemic sclerosis, also known as scleroderma, is an autoimmune disease characterized by cutaneous and visceral fibrosis, immune dysregulation, and vasculopathy. Generally, the degree of skin fibrosis is associated with an increased likelihood of visceral organ involvement. Its pathogenesis is poorl...
Main Authors: | Amy X. Du, Robert Gniadecki, Jan Storek, Mohamed Osman |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-02-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2022.855740/full |
Similar Items
-
Autologous hematopoietic stem cell transplant for progressive diffuse systemic sclerosis: procedural success and clinical outcome in 5-year follow-up
by: Katarzyna Pawlak-Buś, et al.
Published: (2019-02-01) -
Autologous hematopoietic stem cell transplantation improves long-term survival—data from a national registry
by: Norbert Blank, et al.
Published: (2022-11-01) -
Hematopoietic Cell Transplantation for Systemic Sclerosis—A Review
by: Daniel Levin, et al.
Published: (2022-12-01) -
Association Between DNA Damage Response, Fibrosis and Type I Interferon Signature in Systemic Sclerosis
by: Nikolaos I. Vlachogiannis, et al.
Published: (2020-10-01) -
A review of hematopoietic stem cell transplantation for autoimmune diseases: multiple sclerosis, systemic sclerosis and Crohn's disease. Position paper of the Brazilian Society of Bone Marrow Transplantation
by: Maria Carolina Oliveira, et al.
Published: (2021-01-01)